Mark R. Stiles

538 total citations
13 papers, 416 citations indexed

About

Mark R. Stiles is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Mark R. Stiles has authored 13 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Infectious Diseases. Recurrent topics in Mark R. Stiles's work include HIV Research and Treatment (2 papers), Lipid metabolism and biosynthesis (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Mark R. Stiles is often cited by papers focused on HIV Research and Treatment (2 papers), Lipid metabolism and biosynthesis (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Mark R. Stiles collaborates with scholars based in United States, Canada and France. Mark R. Stiles's co-authors include Chad Briscoe, David S. Hage, Daria Stypinski, Joanne M. Donovan, Steven K. Burke, Laura E. Pope, Gerald J. Yakatan, James E. Berg, Edward M. Sellers and Timothy A. Olson and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Analytical and Bioanalytical Chemistry and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Mark R. Stiles

13 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Stiles United States 9 90 68 65 52 50 13 416
Henry J. Pieniaszek United States 15 118 1.3× 74 1.1× 113 1.7× 132 2.5× 51 1.0× 45 699
Jafar Sadik Shaik United States 11 63 0.7× 32 0.5× 35 0.5× 50 1.0× 34 0.7× 21 383
Ching‐Ling Cheng Taiwan 9 81 0.9× 30 0.4× 26 0.4× 70 1.3× 65 1.3× 12 439
Daisy B. Whigan United States 13 173 1.9× 35 0.5× 104 1.6× 83 1.6× 202 4.0× 22 632
Barbara A. Bopp United States 12 188 2.1× 57 0.8× 21 0.3× 60 1.2× 30 0.6× 19 494
Donald W. Everett United States 11 162 1.8× 122 1.8× 59 0.9× 55 1.1× 32 0.6× 12 753
Marc Vermeir Belgium 11 101 1.1× 66 1.0× 21 0.3× 72 1.4× 16 0.3× 17 402
Catherine Z. Matthews United States 17 81 0.9× 53 0.8× 63 1.0× 303 5.8× 87 1.7× 31 615
Toshiro Motoya Japan 13 115 1.3× 118 1.7× 22 0.3× 46 0.9× 19 0.4× 39 518
Donald K. Walker United Kingdom 7 113 1.3× 68 1.0× 10 0.2× 29 0.6× 67 1.3× 10 397

Countries citing papers authored by Mark R. Stiles

Since Specialization
Citations

This map shows the geographic impact of Mark R. Stiles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Stiles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Stiles more than expected).

Fields of papers citing papers by Mark R. Stiles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Stiles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Stiles. The network helps show where Mark R. Stiles may publish in the future.

Co-authorship network of co-authors of Mark R. Stiles

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Stiles. A scholar is included among the top collaborators of Mark R. Stiles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Stiles. Mark R. Stiles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Erdman, Keith, et al.. (2007). Absence of Food Effect on the Extent of Alprazolam Absorption from an Orally Disintegrating Tablet. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(8). 1120–1124. 4 indexed citations
2.
Briscoe, Chad, Mark R. Stiles, & David S. Hage. (2007). System suitability in bioanalytical LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 44(2). 484–491. 80 indexed citations
3.
4.
Marier, Jean‐Francois, Isabelle Morin, Mark R. Stiles, et al.. (2006). Comparative bioavailability of a generic capsule formulation of the reverse transcriptase inhibitor efavirenz and the innovator product. International Journal of Clinical Pharmacology and Therapeutics. 44(4). 180–184. 3 indexed citations
5.
Marier, Jean‐Francois, Laura E. Pope, Gerald J. Yakatan, et al.. (2004). Influence of concomitant quinidine administration on dextromethorphan disposition in rats. Journal of Veterinary Pharmacology and Therapeutics. 27(2). 111–114. 10 indexed citations
6.
Pope, Laura E., et al.. (2004). Pharmacokinetics of Dextromethorphan After Single or Multiple Dosing in Combination With Quinidine in Extensive and Poor Metabolizers. The Journal of Clinical Pharmacology. 44(10). 1132–1142. 94 indexed citations
7.
8.
Zhang, Xiaoping, Keith Nieforth, Régine Rouzier‐Panis, et al.. (2002). Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patientswith human immunodeficiency virus: Inverse Gaussian density absorption and 2‐compartment disposition*. Clinical Pharmacology & Therapeutics. 72(1). 10–19. 52 indexed citations
9.
Donovan, Joanne M., James C. Kisicki, Mark R. Stiles, William Tracewell, & Steven K. Burke. (2002). Effect of Colesevelam on Lovastatin Pharmacokinetics. Annals of Pharmacotherapy. 36(3). 392–397. 22 indexed citations
10.
Donovan, Joanne M., Daria Stypinski, Mark R. Stiles, Timothy A. Olson, & Steven K. Burke. (2000). Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent. Cardiovascular Drugs and Therapy. 14(6). 681–690. 70 indexed citations
11.
Kimanani, Ebi K., Daria Stypinski, Mark R. Stiles, et al.. (2000). A Contract Research Organization's Response to the New FDA Guidances for Bioequivalence/Bioavailability Studies for Orally Administered Drug Products. The Journal of Clinical Pharmacology. 40(10). 1102–1108. 35 indexed citations
12.
Stiles, Mark R., et al.. (1986). Increased fatty acid uptake, a factor in increased hepatic triacylglycerol synthesis in aging rats. Mechanisms of Ageing and Development. 37(1). 49–54. 5 indexed citations
13.
Stiles, Mark R., et al.. (1983). Inhibition by adenosine triphosphate of heart microsomal neutral lipase activity. Lipids. 18(6). 408–411. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry J. Pieniaszek Breakdown of academic impact, for papers by Jafar Sadik Shaik Breakdown of academic impact, for papers by Ching‐Ling Cheng Breakdown of academic impact, for papers by Daisy B. Whigan Breakdown of academic impact, for papers by Barbara A. Bopp Breakdown of academic impact, for papers by Donald W. Everett Breakdown of academic impact, for papers by Marc Vermeir Breakdown of academic impact, for papers by Catherine Z. Matthews Breakdown of academic impact, for papers by Toshiro Motoya Breakdown of academic impact, for papers by Donald K. Walker
Rankless by CCL
2026